Neuropsychiatric disorders and COVID-19 - Authors' reply
- PMID: 34147175
- PMCID: PMC8216633
- DOI: 10.1016/S2215-0366(21)00202-9
Neuropsychiatric disorders and COVID-19 - Authors' reply
Conflict of interest statement
SL is an employee of TriNetX. All other authors declare no competing interests.
Comment on
-
6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.Lancet Psychiatry. 2021 May;8(5):416-427. doi: 10.1016/S2215-0366(21)00084-5. Epub 2021 Apr 6. Lancet Psychiatry. 2021. PMID: 33836148 Free PMC article.
-
Neuropsychiatric disorders and COVID-19.Lancet Psychiatry. 2021 Jul;8(7):563. doi: 10.1016/S2215-0366(21)00177-2. Lancet Psychiatry. 2021. PMID: 34147172 Free PMC article. No abstract available.
-
Neuropsychiatric disorders and COVID-19.Lancet Psychiatry. 2021 Jul;8(7):563-564. doi: 10.1016/S2215-0366(21)00172-3. Lancet Psychiatry. 2021. PMID: 34147173 Free PMC article. No abstract available.
-
Neuropsychiatric disorders and COVID-19.Lancet Psychiatry. 2021 Jul;8(7):564-565. doi: 10.1016/S2215-0366(21)00178-4. Lancet Psychiatry. 2021. PMID: 34147174 Free PMC article. No abstract available.
References
-
- Fragiel M, Miró Ò, Llorens P, et al. Incidence, clinical characteristics, risk factors and outcomes of Guillain-Barré syndrome in patients with COVID-19. Ann Neurol. 2021;89:598–603. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical